Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

Northwest Bioth Cmn (NWBO)

Northwest Bioth Cmn (NWBO)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.4378 +0.0858 (+24.38%) 04/21/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.4390 +0.0012 (+0.27%) 16:00 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3500
Day High
0.4473
Open 0.3805
Previous Close 0.3520 0.3520
Volume 16,975,602 16,975,602
Avg Vol 4,799,215 4,799,215
Stochastic %K 95.81% 95.81%
Weighted Alpha -14.84 -14.84
5-Day Change +0.1953 (+80.54%) +0.1953 (+80.54%)
52-Week Range 0.1685 - 0.5400 0.1685 - 0.5400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 612,583
  • Shares Outstanding, K 1,399,231
  • Annual Sales, $ 1,380 K
  • Annual Income, $ -83,780 K
  • EBIT $ -67 M
  • EBITDA $ -62 M
  • 60-Month Beta -0.67
  • Price/Sales 356.39
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on 03/31/25
  • Next Earnings Date 05/09/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1685 +159.82%
on 04/04/25
Period Open: 0.2529
0.4473 -2.12%
on 04/21/25
+0.1849 (+73.11%)
since 03/21/25
3-Month
0.1685 +159.82%
on 04/04/25
Period Open: 0.2839
0.4473 -2.12%
on 04/21/25
+0.1539 (+54.21%)
since 01/21/25
52-Week
0.1685 +159.82%
on 04/04/25
Period Open: 0.4800
0.5400 -18.93%
on 05/09/24
-0.0422 (-8.79%)
since 04/19/24

Most Recent Stories

More News
Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both %ShuttlePharmaceuticals (Nasdaq: $SHPH) and %NorthwestBiotherapeutics (OTC: $NWBO) are companies that have attracted investor attention due to their promising %Cancer treatments. Both have relatively...

NWBO : 0.4378 (+24.37%)
MRK : 77.85 (-0.19%)
SHPH : 0.2508 (-1.07%)
BMY : 48.94 (-0.59%)
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics and Advent BioServices Announce Receipt of License for Commercial Manufacturing at Sawston, U.K. Facility

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews 2022 Progress and Looks Forward to Strong 2023

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Cohen Milstein Files Lawsuit on Behalf of Northwest Biotherapeutics Against Major Market Makers for Market Manipulation

NEW YORK, Dec 2, 2022 - (ACN Newswire) - Today, Northwest Biotherapeutics (OTCQB:NWBO) filed a lawsuit against some of the largest and most influential market makers in the world, including Citadel Securities...

NWBO : 0.4378 (+24.37%)
0K95.LN : 0.481 (+2.34%)
Northwest Biotherapeutics Reports Positive Top-Line Results From Phase 3 Trial of DCVax®-L for Glioblastoma

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)
Northwest Biotherapeutics Announces Approval of Pediatric Investigation Plan (PIP) by MHRA

/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...

NWBO : 0.4378 (+24.37%)

Business Summary

Northwest Biotherapeutics, Inc. is a biotechnology company focused on discovering, developing, and commercializing immunotherapy products that safely generate and enhance immune system responses to treat cancer.

See More

Key Turning Points

3rd Resistance Point 0.5707
2nd Resistance Point 0.5090
1st Resistance Point 0.4734
Last Price 0.4378
1st Support Level 0.3761
2nd Support Level 0.3144
3rd Support Level 0.2788

See More

52-Week High 0.5400
Last Price 0.4378
Fibonacci 61.8% 0.3981
Fibonacci 50% 0.3543
Fibonacci 38.2% 0.3104
52-Week Low 0.1685

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro